Phase 1/2 trial of AXO-AAV-GM1 (AAV9-GLB1) gene therapy for infantile- and juvenile-onset GM1 gangliosidosis

被引：0

作者：

Tifft, Cynthia ^{[1
]}

D'Souza, Precilla ^{[1
]}

Johnston, Jean M. ^{[1
]}

Acosta, Maria T. ^{[1
]}

Nicoli, Elena-Raluca ^{[1
]}

Rothermel, Caroline ^{[1
]}

Thurm, Audrey ^{[2
]}

Karunakara, Ajith ^{[3
]}

Thorp, Benjamin ^{[3
]}

Ross, Peter ^{[3
]}

Jameson, John ^{[3
]}

Sheehan, Michael ^{[3
]}

Vaughn, Toby ^{[3
]}

Valencia, Donna ^{[3
]}

De Boever, Erika ^{[3
]}

Corcoran, Gavin ^{[3
]}

机构：

[1] Nat Human Genome Res Inst, Bethesda, MD USA

[2] Nat Inst Mental Hlth, Bethesda, MD USA

[3] Sio Gene Therapies Inc, New York, NY USA

来源：

MOLECULAR GENETICS AND METABOLISM | 2022年 / 135卷 / 02期

关键词：

D O I：

10.1016/j.ymgme.2021.11.317

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

302

引用

页码：S119 / S119

页数：1

共 50 条

[31] An engineered β-galactosidase with improved stability and crosscorrection for the potential treatment of GM1 Gangliosidosis via AAV gene therapy
Reddy, Charu
Onguka, Ouma
Artz, Jacob
Schmitt, Christopher
Grossman, Adam
Santosh, Swetha
Akinkugbe, Oluwayomi
Wong, Victoria
Gebretsadik, Kahsay
Sedighi, Faezeh
Tang, Jinyan
Del Greco, Elizabeth
Lee, Grace S.
Kruse, Nikki
Chng, Chinping
Duan, Da
Hallows, William C.
Chen, Joseph C.
Akeefe, Hassibullah
Silverman, Adam P.
Huisman, Gjalt
MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 109 - 109
[32] Paramagnetic Signals in the Globus Pallidus as Late Radiographic Sign of Juvenile-Onset GM1 Gangliosidosis
Takenouchi, Toshiki
Kosaki, Rika
Nakabayashi, Kazuhiko
Hata, Kenichiro
Takahashi, Takao
Kosaki, Kenjiro
PEDIATRIC NEUROLOGY, 2015, 52 (02) : 226 - 229
[33] Adeno-Associated Viral (AAV) Vector-Mediated GLB1 Gene Transfer Reduces Substrate Accumulations in a Murine Model of GM1 Gangliosidosis
Ni, Yan G.
Gelb, Michael
Herbst, Zachary
Vrentas, Catherine
Messick, Elyse
Weinstein, David A.
Browne, Susan E.
Wilson, James M.
Hinderer, Christian
MOLECULAR THERAPY, 2023, 31 (04) : 388 - 388
[34] Identification of a novel GLB1 mutation in a consanguineous Pakistani family affected by rare infantile GM1 gangliosidosis
Bibi Zubaida
Muhammad Almas Hashmi
Huma Arshad Cheema
Muhammad Naeem
Journal of Genetics, 2018, 97 : 1445 - 1449
[35] Identification of a novel GLB1 mutation in a consanguineous Pakistani family affected by rare infantile GM1 gangliosidosis
Zubaida, Bibi
Hashmi, Muhammad Almas
Cheema, Huma Arshad
Naeem, Muhammad
JOURNAL OF GENETICS, 2018, 97 (05) : 1445 - 1449
[36] Presymptomatic Gene Therapy Cures Feline GM1 Gangliosidosis
McCurdy, Victoria J.
Johnson, Aime K.
Bradbury, Allison M.
Randle, Ashley N.
Gray-Edwards, Heather
Hwang, Misako
Leroy, Stanley G.
Cox, Nancy R.
Sena-Esteves, Miguel
Martin, Douglas R.
MOLECULAR THERAPY, 2012, 20 : S12 - S12
[37] Robust clinical outcome measures for patients with juvenile onset GM1 gangliosidosis
Glase, Brianna
Johnston, Jean
D'Souza, Precilla
Adedipe, Dee
Farmer, Cristan
Thurm, Audrey
Tifft, Cynthia
MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S61 - S61
[38] Treatment of Feline GM1 Gangliosidosis by Cerebrospinal Fluid Delivery of AAV9 or AAVrh10
Garrett, Courtney
Gross, Amanda L.
Gray-Edwards, Heather
Sena-Esteves, Miguel
Martin, Douglas R.
MOLECULAR THERAPY, 2021, 29 (04) : 179 - 180
[39] Gene Editing Corrects In Vitro a G > A GLB1 Transition from a GM1 Gangliosidosis Patient
Leclerc, Delphine
Goujon, Louise
Jaillard, Sylvie
Nouyou, Benedicte
Cluzeau, Laurence
Damaj, Lena
Dubourg, Christele
Etcheverry, Amandine
Levade, Thierry
Froissart, Roseline
Dreano, Stephane
Guillory, Xavier
Eriksson, Leif A.
Launay, Erika
Mouriaux, Frederic
Belaud-Rotureau, Marc-Antoine
Odent, Sylvie
Gilot, David
CRISPR JOURNAL, 2023, 6 (01): : 17 - 31
[40] Base editing of the GLB1 gene is therapeutic in GM1 gangliosidosis patient-derived cells
Rha, Allisandra K.
Kan, Shih-Hsin
Andrade-Heckman, Perla
Christensen, Chloe L.
Harb, Jerry F.
Wang, Raymond Y.
MOLECULAR GENETICS AND METABOLISM, 2024, 143 (1-2)

← 1 2 3 4 5 →